Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Quantum Biopharma ( (TSE:QNTM) ) is now available.
Quantum BioPharma clarified that it has not changed its name following misinformation on stock trading platforms and social media suggesting a name change to Unbuzzd Wellness Inc. and a reverse takeover. The company remains the largest shareholder of Unbuzzd Wellness Inc., with a financial agreement that includes royalties and shares, and it has settled a debt with vendors using Class B Shares.
More about Quantum Biopharma
Quantum BioPharma is a biopharmaceutical company focused on developing innovative assets and biotech solutions for treating neurodegenerative, metabolic, and alcohol misuse disorders. The company is actively involved in the research and development of its lead compound, Lucid-MS, aimed at addressing multiple sclerosis, and has a stake in Unbuzzd Wellness Inc., which markets the product unbuzzd™.
Average Trading Volume: 8,376
Technical Sentiment Signal: Hold
Current Market Cap: C$53.79M
See more insights into QNTM stock on TipRanks’ Stock Analysis page.